Clinical Study

Timing of Hepatic Artery Reperfusion and Biliary Strictures in Liver Transplantation

Table 1

Descriptive characteristics of patients with and without biliary strictures undergoing OLT from 2007 to 2009.

VariableOLT without biliary strictures ( )OLT with biliary strictures ( ) value

Age, years, mean ± sd (range) (18.0–75.0) (37.0–70.0)0.99
Male, % ( )72.3 (47)80.0 (8)0.60
Etiology, % ( )
 HCC27.7 (18)30.0 (3)0.57
  ALF/fulminant4.6 (3)10.0 (1)0.44
  HCV/ETOH4.6 (3)10.0 (1)0.44
  HCV21.5 (14)20.0 (2)0.63
  HBV 3.1 (2)0.0 (0)0.75
  PSC3.1 (2)0.0 (0)0.75
  NASH3.1 (2)0.0 (0)0.75
  Cryptogenic10.8 (7)20.0 (2)0.34
MELD, mean ± sd (range) (6.0–44.0) (6.0–48.0)0.42
Graft survival, months, mean ± sd (range) (3.0–45.0) (12.0–40.0)0.99
Alive, % ( )86.2 (56)90.0 (9)0.74
PVRP-HARP, minutes, mean ± sd (range) (10–189) (26–119)0.81
Warm ischemia time (WIT; minutes) mean ± sd (range) (20–60) (36–69)0.06
Cold ischemia time (CIT; minutes) mean ± sd (range) (38–756) (277–631)0.03*

Statistically significant.